Table 1.

Study enrolment criteria

Case		Control
Inclusion	Exclusion	Inclusion	Exclusion
Age >2 years and <18 years	Do not fulfil inclusion criteria	Age >2 years and <18 years	Do not fulfil inclusion criteria
Treated for VL in the past	Lesions with mucosal involvement	Treated for VL in the past	Serious concomitant illness
Currently with skin lesions such as PKDL	Serious concomitant illness	Currently with no skin lesions such as PKDL	Cannot be followed up
Positive for Leishmania donovani bodies by microscopy and or DNA by qPCR in their skin	Cannot be followed up	Clinically healthy and free from other chronic illness	Controls with PKDL during follow-up
Clinically healthy and free from other chronic illness	Female married adolescent	Received no treatment for PKDL
Received no treatment for PKDL in the last 6 months		Normal hepatic, renal and haematological functions
Normal hepatic, renal and haematological functions		Parent/guardian provided informed voluntary written consent for his/her child participation
Parent/guardian provided informed voluntary written consent for his/her child participation

PKDL, post-kala-azar dermal leishmaniasis; qPCR, quantitative PCR; VL, visceral leishmaniasis.